Latest news
Is Editas Medicine (EDIT) Outperforming Other Medical Stocks This Year? - Yahoo FinanceYahoo Finance · Mon, 10 Aug 2026 13:40:02 GMTEditas Medicine, Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Mon, 10 Aug 2026 11:59:42 GMTHC Wainwright Boosts Earnings Estimates for Editas Medicine - MarketBeatMarketBeat · Mon, 10 Aug 2026 05:13:31 GMTWall Street Zen Upgrades Editas Medicine (NASDAQ:EDIT) to Hold - MarketBeatMarketBeat · Sat, 08 Aug 2026 05:48:57 GMTH.C. Wainwright Maintains Editas Medicine(EDIT.US) With Buy Rating, Maintains Target Price $5 - MoomooMoomoo · Sat, 08 Aug 2026 03:45:24 GMTEditas Medicine (NASDAQ: EDIT) grants director 103400 options at $2.9000 - Stock TitanStock Titan · Fri, 07 Aug 2026 21:16:53 GMTEditas Medicine, Inc. (EDIT) director reports no share or option holdings - Stock TitanStock Titan · Fri, 07 Aug 2026 21:16:37 GMTEditas Medicine director Ellinor Patrick Thomas II files initial beneficial ownership statement - BitgetBitget · Fri, 07 Aug 2026 13:16:29 GMT